HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.

AuthorsB C Medeiros, L Tian, S Robenson, G G Laport, L J Johnston, J A Shizuru, D B Miklos, S Arai, J E Benjamin, W-K Weng, R S Negrin, R Lowsky
JournalBlood cancer journal (Blood Cancer J) Vol. 4 Pg. e216 (May 30 2014) ISSN: 2044-5385 [Print] United States
PMID24879117 (Publication Type: Letter, Research Support, N.I.H., Extramural)
Topics
  • Adolescent
  • Adult
  • Aged
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation (methods)
  • Humans
  • Leukemia, Myeloid, Acute (therapy)
  • Male
  • Middle Aged
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: